Table 1.
General features of patients included in the study.
| RA (n = 21) | SLE (n = 55) | PMR (n = 10) | AAV (n = 63) | GCA (n = 96) | TA (n = 42) | |
|---|---|---|---|---|---|---|
| Age at diagnosis (year) | ND | 26.2 (18.6- 34.2) |
72.0 (68.5- 73) |
48.5 (36.5 - 61.5) |
74.0 (67.0 - 77.0) |
30.0 (24.0 - 40.5) |
| Age at sampling (years) | 63.0 (43.0- 67.0) |
38.2 (31.2- 48.9) |
73.0 (69.3- 77) |
59.5 (47.8 - 67.9) |
75.2 (69.4 - 79.5) |
46.0 (35 - 53) |
| ESR (mm/h) | 16.5 (12.8 - 23.5) |
20.0 (7.0 - 38.5) |
30.0 (20.0 - 50.0) |
13.0 (6.5- 31.5) |
31.0 (18.0 - 57.8) |
15 (7.8- 30.3) |
| CRP (mg/l) | 3.5 (2 - 6.7) |
2.1 (0.3 - 6.1) |
10.4 (8.7 - 22.3) |
0.8 (0.23 - 6.2) |
11.0 (2.26 - 31.4) |
2.25 (1.03 - 7.3) |
| PDN dose at sampling (mg/day) | 5.0 (2.5 - 5) |
3.8 (0.0 - 5.0) |
1.9 (0.0 - 17.2) |
5.0 (5.0 - 6.5) |
5.0 (0.0 - 12.5) |
5.0 (0.0 - 5.0) |
| Z-activity | −0.42 (−0.47 - −0.28) |
−0.33 (−0.56 - 0.35) |
NA | −0.4 (−0.4- −0.07) |
−0.23 (−0.23 - −0.07) |
−0.42 (−0.47 - −0.28) |
| Z-damage | ND | −0.2 (−0.2 - −0.07) |
NA | −0.06 (−0.06 - 0.01) |
−0.14 (−0.14 - −0.06) |
−0.12 (−0.57 - 0.19) |